|

CE1226 Clinical Trials

1 actively recruiting trial

Also known as: Human alpha1-proteinase inhibitor, Respreeza, Zemaira

Pipeline

Phase 4: 1

Top Sponsors

  • CSL Behring1

Indications

  • Alpha1-Proteinase Inhibitor Deficiency1
  • Alpha1-Antitrypsin Deficiency1
  • Liver Disease1
  • Emphysema1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.